USPTO serial 75190553
INDAS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- POWERS, ALEXANDER L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INDAS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
County Westmeath, IE
County Westmeath, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARLA J CHURCH
MARLA J CHURCH ELAN PHARMACEUTICAL RESEARCH CORPORATION1300 GOULD DRGAINESVILLE, GA 30504UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | tablet matrix used to improve the solubility and absorption characteristics of poorly water soluble drugs sold as an integral component of various oral pharmaceuticals such as antacids, antispasmodics and anti-ulcerants, laxatives, anti-diarrhoeals, colorectal agents, cardiac drugs, drugs for the treatment of disorders of the central nervous system, central nervous system stimulants, analgesics, antipyretics and anti-inflammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchoodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, preparations that reduce sensitization of inflamation, erythema, and odema, local and general anesthetics, oral and transdermal contraceptives, pharmaceutical preparations for the treatment of dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells, and medical diagnostic reagents, for administration to humans | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 17, 2001 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 19, 2000 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 12, 2000 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 10, 1999 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 6, 1999 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 13, 1999 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 13, 1999 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 13, 1998 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 21, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| May 4, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 1998 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Mar 13, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| May 12, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 16, 1996 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |